Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A modular RNA delivery system comprising spherical nucleic acids built on endosome-escaping polymeric nanoparticles†

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nucleic acid therapeutics require delivery systems to reach their targets. Key challenges to be overcome include avoidance of accumulation in cells of the mononuclear phagocyte system and escape from the endosomal pathway. Spherical nucleic acids (SNAs), in which a gold nanoparticle supports a corona of oligonucleotides, are promising carriers for nucleic acids with valuable properties including nuclease resistance, sequence-specific loading and control of receptor-mediated endocytosis. However, SNAs accumulate in the endosomal pathway and are thus vulnerable to lysosomal degradation or recycling exocytosis. Here, an alternative SNA core based on diblock copolymer PMPC 25–PDPA 72 is investigated. This pH-sensitive polymer self-assembles into vesicles with an intrinsic ability to escape endosomes via osmotic shock triggered by acidification-induced disassembly. DNA oligos conjugated to PMPC 25–PDPA 72 molecules form vesicles, or polymersomes, with DNA coronae on luminal and external surfaces. Nucleic acid cargoes or nucleic acid-tagged targeting moieties can be attached by hybridization to the coronal DNA. These polymeric SNAs are used to deliver siRNA duplexes against C9orf72, a genetic target with therapeutic potential for amyotrophic lateral sclerosis, to motor neuron-like cells. By attaching a neuron-specific targeting peptide to the PSNA corona, effective knock-down is achieved at doses of 2 particles per cell.

          Abstract

          Polymeric spherical nucleic acids comprise pH-sensitive, polymer-conjugated oligonucleotides that self-assemble into nanoparticles with the ability to escape endosomes, overcoming a major obstacle in nucleic acid delivery.

          Related collections

          Author and article information

          Journal
          Nanoscale Adv
          Nanoscale Adv
          NA
          NAADAI
          Nanoscale Advances
          RSC
          2516-0230
          10 May 2023
          30 May 2023
          10 May 2023
          : 5
          : 11
          : 2941-2949
          Affiliations
          [a ] Department of Physics, Clarendon Laboratory, University of Oxford Parks Road Oxford OX1 3PU UK
          [b ] Department of Paediatrics, University of Oxford Le Gros Clark Building, South Parks Road Oxford OX1 3QX UK
          [c ] Kavli Institute for Nanoscience Discovery, University of Oxford Dorothy Crowfoot Hodgkin Building, South Parks Road Oxford OX1 3QU UK andrew.turberfield@ 123456physics.ox.ac.uk +44-1865-272359
          [d ] Institute of Developmental and Regenerative Medicine (IDRM) IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington Oxford OX3 7TY UK antonio.garciaguerra@ 123456paediatrics.ox.ac.uk +44-1865-272166
          [e ] Department of Chemistry, University College London London WC1H 0AJ UK
          [f ] Leibniz Institute for Polymer Research Dresden Hohe Str. 6 01069 Dresden Germany
          [g ] Institute for Bioengineering of Catalonia, Barcelona Institute of Science and Technology Baldiri Reixac, 10-12 08028 Barcelona Spain
          [h ] Catalan Institution for Research and Advanced Studies Passeig de Lluís Companys, 23 08010 Barcelona Spain
          [i ] Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza Zaragoza 50013 Spain
          Author notes
          [‡]

          These authors share senior co-authorship.

          Author information
          https://orcid.org/0000-0003-1350-3558
          https://orcid.org/0000-0001-7978-9873
          https://orcid.org/0000-0002-8858-982X
          https://orcid.org/0000-0002-7144-662X
          https://orcid.org/0000-0001-7809-4949
          https://orcid.org/0000-0003-4376-9381
          https://orcid.org/0000-0003-3349-6770
          https://orcid.org/0000-0002-5436-6011
          https://orcid.org/0000-0002-7477-8742
          https://orcid.org/0000-0002-8307-6638
          https://orcid.org/0000-0002-3876-0190
          Article
          d2na00846g
          10.1039/d2na00846g
          10228346
          37260495
          7b970fd2-b25c-4ac9-a8a8-877798706621
          This journal is © The Royal Society of Chemistry
          History
          : 24 November 2022
          : 4 April 2023
          Page count
          Pages: 9
          Funding
          Funded by: Medical Research Council, doi 10.13039/501100000265;
          Award ID: MC-PC-16056
          Funded by: FP7 People: Marie-Curie Actions, doi 10.13039/100011264;
          Award ID: 317110
          Funded by: Biotechnology and Biological Sciences Research Council, doi 10.13039/501100000268;
          Award ID: BB/S50676X/1
          Funded by: Wellcome Trust, doi 10.13039/100010269;
          Award ID: 205162/Z/16/Z
          Categories
          Chemistry
          Custom metadata
          Paginated Article

          Comments

          Comment on this article